Market capitalization | $11.50b |
Enterprise Value | $11.25b |
P/E (TTM) P/E ratio | 74.82 |
EV/FCF (TTM) EV/FCF | 47.80 |
EV/Sales (TTM) EV/Sales | 6.30 |
P/S ratio (TTM) P/S ratio | 6.45 |
P/B ratio (TTM) P/B ratio | 20.92 |
Revenue growth (TTM) Revenue growth | 85.99% |
Revenue (TTM) Revenue | $1.78b |
As a Free StocksGuide user, you can view scores for all 6,791 stocks worldwide.
16 Analysts have issued a Hims & Hers Health Inc. forecast:
16 Analysts have issued a Hims & Hers Health Inc. forecast:
Mar '25 |
+/-
%
|
||
Revenue | 1,784 1,784 |
86%
86%
|
|
Gross Profit | 1,217 1,217 |
63%
63%
|
|
EBITDA | 138 138 |
4,622%
4,622%
|
EBIT (Operating Income) EBIT | 116 116 |
959%
959%
|
Net Profit | 164 164 |
7,096%
7,096%
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.
Head office | United States |
CEO | Andrew Dudum |
Employees | 1,637 |
Founded | 2017 |
Website | www.forhims.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.